Disease/Infection News

RSS

Statistical model builds SARS-CoV-2 interactome with miRNAs, protein-coding genes, and co-infecting microbes

A team of researchers recently developed a statistical modeling method known as multiple-layer crosstalk (MLCrosstalk).

12 Dec 2021

Effect of mutations on SARS-CoV-2 E protein interactions with cell junctions

In a recent study, ten human PDZ-containing proteins showed significant interactions with the SARS-CoV-2 E protein in a PBM-dependent manner.

12 Dec 2021

Even if SARS-CoV-2 Omicron evades antibodies, immunity still exists

Researchers determined antibody-mediated neutralization efficacy against the authentic SARS-CoV-2 Omicron variant.

12 Dec 2021

A pandemic-scale phylogenetic analysis tool

Researchers develop a phylogenetic package that incorporated several pandemic-specific optimization and parallelization techniques.

12 Dec 2021

A new rapid and inexpensive PCR method to detect SARS-CoV-2 Omicron variant

A new study reports a method using four PCR tests to distinguish infection with the Omicron variant from that caused by other variants.

12 Dec 2021

New tool to help map immune escape with SARS-CoV-2 mutations

A new study discusses a computational program that can be used to substitute for actual experimental evidence of the biologic impact of new mutations.

12 Dec 2021

UK Prime Minister and the NHS launch urgent appeal calling for people to get Covid jabs

The Prime Minister, together with the NHS, has today [Sunday 12 December] launched an urgent national appeal calling for people to get jabbed, as he outlined plans to significantly increase NHS vaccination capacity.

12 Dec 2021

Vaccinated, previously-infected people could have some "stronger than basic" defense against Omicron variant

Published today, one of the earliest, peer-reviewed studies looking into the Omicron variant of COVID-19 suggests that people previously infected with COVID, and those vaccinated, will have some, "stronger than basic" defense against this new strain of concern.

12 Dec 2021

Health experts recommend the increase in UK COVID-19 alert level from Level 3 to Level 4

Following advice from the UK Health Security Agency and in the light of the rapid increase in Omicron cases, the UK Chief Medical Officers and NHS England National Medical Director have recommended to ministers that the UK COVID-19 alert level should increase from Level 3 to Level 4.

12 Dec 2021

Fully vaccinated contacts of a COVID-19 case should take daily rapid tests for 7 days

From Tuesday 14 December, people who are fully vaccinated and identified as a contact of someone with COVID-19 - whether Omicron or not - should take an NHS rapid lateral flow test every day for 7 days to help slow the spread of COVID-19.

12 Dec 2021

First locally acquired infection of Omicron variant confirmed in San Diego

Officials at the San Diego County Health and Human Services Agency, working in collaboration with scientists at University of California San Diego and Scripps Research, have announced the second confirmed case — and first locally acquired infection — of the Omicron variant of SARS-CoV-2, the virus that causes COVID-19.

12 Dec 2021

LSHTM's new modeling estimates the potential impact of omicron in England

New modeling from the London School of Hygiene & Tropical Medicine suggests the Omicron variant has the potential to cause a wave of transmission in England that could lead to higher levels of cases and hospitalizations than those seen during January 2021, if additional control measures are not taken.

12 Dec 2021

Formula 1's biggest stars urge all fans to get their COVID-19 vaccine

Formula 1's biggest stars have backed the UK's vaccine rollout and urged all fans to get their jab as soon as possible this winter in a new film out today (Saturday 11 December).

12 Dec 2021

UTSW study points to a new way to fight parasitic nematode diseases

Combining two agents to block a parasitic worm's life cycle boosted survival from a potentially deadly tropical disease to 85% in animal models, far better than either treatment alone, according to a proof-of-concept study led by UT Southwestern Medical Center pharmacologists.

11 Dec 2021

UTEP to develop new initiative to reduce HIV in people who use drugs in the El Paso-Ciudad Juárez border

The University of Texas at El Paso will develop a sustainable public health intervention to suppress human immunodeficiency virus (HIV) in people who use drugs in the El Paso-Ciudad Juárez border region to help slow the spread of HIV.

11 Dec 2021

Nasal vaccine provides broad-based protection against heterologous respiratory viruses in mice

The emergence of COVID-19 variants such as delta and omicron have sent scientists scrambling to determine whether existing vaccinations and boosters are still effective against new strains of SARS-Cov-2.

11 Dec 2021

UCLA research points the way towards a longer-lasting COVID vaccine

Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified rare, naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses.

11 Dec 2021

New insights about COVID-19 vaccination rates among people living with HIV

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that insights around COVID-19 vaccination rates among people living with HV have been published in the Journal of Infectious Diseases.

10 Dec 2021

COVID-19 booster program accelerated, 22 million people in the UK have received top-up jabs

More than 22 million people in the UK have now received a COVID-19 top up jab, as the booster programme is accelerated this winter.

10 Dec 2021

Impact of environmental SARS-CoV-2 contamination in residential housing

In a new study, scientists hypothesize that the presence of Corynebacterium and SARS-CoV-2 in surface samples might be associated with skin contamination.

10 Dec 2021

Disease/Infection News

Statistical model builds SARS-CoV-2 interactome with miRNAs, protein-coding genes, and co-infecting microbes

Effect of mutations on SARS-CoV-2 E protein interactions with cell junctions

Even if SARS-CoV-2 Omicron evades antibodies, immunity still exists

A pandemic-scale phylogenetic analysis tool

A new rapid and inexpensive PCR method to detect SARS-CoV-2 Omicron variant

New tool to help map immune escape with SARS-CoV-2 mutations

UK Prime Minister and the NHS launch urgent appeal calling for people to get Covid jabs

Vaccinated, previously-infected people could have some "stronger than basic" defense against Omicron variant

Health experts recommend the increase in UK COVID-19 alert level from Level 3 to Level 4

Fully vaccinated contacts of a COVID-19 case should take daily rapid tests for 7 days

First locally acquired infection of Omicron variant confirmed in San Diego

LSHTM's new modeling estimates the potential impact of omicron in England

Formula 1's biggest stars urge all fans to get their COVID-19 vaccine

UTSW study points to a new way to fight parasitic nematode diseases

UTEP to develop new initiative to reduce HIV in people who use drugs in the El Paso-Ciudad Juárez border

Nasal vaccine provides broad-based protection against heterologous respiratory viruses in mice

UCLA research points the way towards a longer-lasting COVID vaccine

New insights about COVID-19 vaccination rates among people living with HIV

COVID-19 booster program accelerated, 22 million people in the UK have received top-up jabs

Impact of environmental SARS-CoV-2 contamination in residential housing

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News